Biden Administration Unveils the 10 Prescription Drugs That Will Be Subject to Medicare Price Negotiations

The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations with Medicare, marking a milestone for Democrats in their yearslong push to lower rising health care costs.

The list includes Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp/NovoLog insulin products.

President Joe Biden, in remarks at the White House, said the medications are “drugs to treat everything from heart failure, blood clots, diabetes, kidney disease, arthritis, blood cancers, Crohn’s disease and so much more.”

Read the source article at ABC News